Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HBB | P68871 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | EP300 | Q09472 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27943834 | 1.00 | MCL1 (0.39) | MCL1HTTMAPTALOX15HBB | |
| Dimethylformamide SCHEMBL27485383 | 0.90 | MCL1 (0.33) | MCL1HTTALDH1A1LMNAPKM | |
| SCHEMBL1934695 | 0.89 | MCL1 (0.46) | MCL1HTTMAPTALOX15HBB | |
| Ammonia Solution, Strong SCHEMBL28851009 | 0.88 | MCL1 (0.45) | MCL1HTTMAPTALOX15HBB | |
| SCHEMBL27451802 | 0.79 | MCL1 (0.39) | MCL1HTTMAPTALOX15HBB | |
| SCHEMBL44224 | 0.76 | ALDH1A1 (0.45) | MCL1HTTMAPTALOX15HBB | |
| Benzoic Acid SCHEMBL27698997 | 0.74 | DAO (0.45) | ALDH1A1POLBL3MBTL1MEN1KMT2A | |
| SCHEMBL30817647 | 0.73 | MCL1 (0.44) | MCL1HTTMAPTALOX15HBB | |
| SCHEMBL5009138 | 0.72 | KDM4E (0.55) | MAPTALDH1A1LMNAPOLBGAA | |
| SCHEMBL2222585 | 0.72 | DDAH1 (0.51) | HTTALDH1A1LMNAPKMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102666879-A | Templated nanoconjugates | UNIV NORTHWESTERN | 2012-09-12 | — | — | CN | claimed |
| EP-1704167-B1 | A METHOD TO MAKE A PEPTIDE-CARRIER CONJUGATE WITH A HIGH IMMUNOGENICITY | ANGELETTI P IST RICHERCHE BIO (IT) | 2011-01-12 | — | — | EP | claimed |
| EP-0366770-B1 | LIPOSOMES COUPLED TO HORMONES | VESTAR INC (US) | 1994-02-09 | — | — | EP | claimed |
| CN-116762002-A | Sensor for unbiased proteome studies, methods of making and using the same | 纳米马赛克公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-110506055-A | Engineered TfR combination polypeptide | DENALI THERAPEUTICS INC | 2019-11-26 | — | — | CN | disclosed |
| CN-110506054-A | Engineered polypeptide | DENALI THERAPEUTICS INC | 2019-11-26 | — | — | CN | disclosed |
| EP-3058954-A2 | IMMUNOGENIC COMPOSITIONS AND METHODS | Longhorn Vaccines and Diagnostics, LLC (US) | 2016-08-24 | — | — | EP | disclosed |
| CN-103596985-B | Human monoclonal antibodies specific for glypican 3 and uses thereof | 美国政府(由卫生和人类服务部的部长所代表) | 2016-06-08 | — | — | CN | disclosed |
| EP-2417457-B1 | PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMA | VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORG (NL) | 2015-05-13 | — | — | EP | disclosed |
| CN-102781960-B | HSA-related compositions and methods of use | MEDIMMUNE LLC | 2014-12-10 | — | — | CN | disclosed |
| CN-101802211-B | Anti-normal T cell expression and secretion activating regulatory factor (RANTES) antibodies and methods of use thereof | NOVIMMUNE S.A. (CH) | 2014-10-01 | — | — | CN | disclosed |
| CN-1317343-A | Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor | SCHERING CORP (US) | 2001-10-17 | — | — | CN | disclosed |
| CN-1317569-A | Method for preparing mammal cell kinetin synthesis inhibiting factor | SCHERING CORP (US) | 2001-10-17 | — | — | CN | disclosed |
| CN-1295579-A | Therapeutic uses of keratinocyte growth factor-2 | HUMAN GENOME SCIENCES INC (US) | 2001-05-16 | — | — | CN | disclosed |
| EP-1064375-A2 | HUMAN CALCIUM-BINDING PROTEINS | Incyte Pharmaceuticals, Inc. (US) | 2001-01-03 | — | — | EP | disclosed |
| EP-1056869-A2 | CELL CYCLE RELATED PROTEINS | INCYTE PHARMACEUTICALS, INC. (US) | 2000-12-06 | — | — | EP | disclosed |
| CN-1233187-A | HIVp-17 peptide fragments, compositions containing the same, and methods of making and using the same | VIRAL TECHNOLOGIES INC (US) | 1999-10-27 | — | — | CN | disclosed |
| WO-1999049038-A2 | HUMAN CALCIUM-BINDING PROTEINS | INCYTE PHARMACEUTICALS, INC. (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999043829-A2 | CELL CYCLE RELATED PROTEINS | INCYTE PHARMACEUTICALS, INC. (US) | 1999-09-02 | — | — | WO | disclosed |
| CN-1051393-A | Cytokine synthesis inhibitory factor, antagonists thereof and methods of use thereof | SCHERING CORP (US) | 1991-05-15 | — | — | CN | disclosed |